A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
NCT00912730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2009-10-21
Summary
This is a single-institution pilot study seeking preliminary evidence of the usefulness of mobile gamma cameras in patients undergoing sentinel node biopsy for melanoma.
Conditions
Sponsors & Collaborators
-
University of Virginia
lead OTHER
Principal Investigators
-
Craig L Slingluff, MD · University of Virginia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors
NCT03057509 ·Status: WITHDRAWN ·Phase: PHASE1
-
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
NCT04941430 ·Status: TERMINATED ·Phase: NA
-
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
NCT07303725 ·Status: RECRUITING
-
PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
NCT02307630 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
NCT01266096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
NCT06199713 ·Status: RECRUITING
-
Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors
NCT00954148 ·Status: TERMINATED ·Phase: NA
-
The National Oncologic PET Registry
NCT00868582 ·Status: UNKNOWN
-
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
NCT01575951 ·Status: COMPLETED ·Phase: NA
-
Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
NCT01873469 ·Status: COMPLETED
-
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
NCT05933239 ·Status: RECRUITING ·Phase: PHASE2
-
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
NCT02130492 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
NCT00604266 ·Status: WITHDRAWN
-
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT
NCT00823810 ·Status: TERMINATED ·Phase: NA
-
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
NCT00832598 ·Status: COMPLETED ·Phase: NA
-
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 ·Status: COMPLETED
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab
NCT05259709 ·Status: RECRUITING ·Phase: PHASE1
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
NCT03057743 ·Status: TERMINATED
-
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
NCT01109953 ·Status: TERMINATED
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3